Fabian Tenenbaum is the founder of Nectin Therapeutics. Nectin Therapeutics has raised $25M in total funding. Latest round: Series A.
Fabian Tenenbaum is the Chief Executive Officer of Nectin Therapeutics, an Israeli biotechnology company focused on developing novel immuno-oncology therapies. He has led the company through multiple funding rounds, reaching over $25 million in total funding to support clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library